APO Research
Talk to an analyst

APO RESEARCH · REPORT

FIC Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FIC Drugs Industry Growth and Trends Forecast to 2032

28 December 2025116 pages

Choose your research edition.

Industry ResearchFIC Drugs Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal FIC Drugs Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal FIC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FIC Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal FIC Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global FIC Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FIC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FIC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FIC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FIC Drugs include Agios, BMS, Boehringer Ingelheim, Dermavant Sciences, Genentech, Gilead, Immunocore, ImmunoGen and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FIC Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FIC Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FIC Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FIC Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global FIC Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FIC Drugs Market by Company

Agios

BMS

Boehringer Ingelheim

Dermavant Sciences

Genentech

Gilead

Immunocore

ImmunoGen

Mallinckrodt

Marinus

Phathom

Polarean lmaging

Pfizer

Eli Lilly

Roche

Merck

Novartis

Johnson & Johnson

Sanofi

FIC Drugs Segment by Type

FIC Single-target Drugs

FIC Dual-target Drugs

FIC Drugs Segment by Application

Hospital

Clinic

Other

FIC Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FIC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FIC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FIC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FIC Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of FIC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of FIC Single-target Drugs Table 2. Major Company of FIC Dual-target Drugs Table 3. Global FIC Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global FIC Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global FIC Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global FIC Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global FIC Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global FIC Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global FIC Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global FIC Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global FIC Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global FIC Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America FIC Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe FIC Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific FIC Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America FIC Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa FIC Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa FIC Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. FIC Drugs Industry Trends Table 25. FIC Drugs Industry Drivers Table 26. FIC Drugs Industry Opportunities and Challenges Table 27. FIC Drugs Industry Restraints Table 28. Global FIC Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global FIC Drugs Revenue Market Share by Company (2021-2026) Table 30. Global FIC Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global FIC Drugs Sales Share by Company (2021-2026) Table 32. Global FIC Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global FIC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global FIC Drugs Major Company Production Sites and Headquarters Table 35. Global FIC Drugs Company, Product Type & Application Table 36. Global FIC Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global FIC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global FIC Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global FIC Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global FIC Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global FIC Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global FIC Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global FIC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global FIC Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global FIC Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global FIC Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global FIC Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global FIC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global FIC Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global FIC Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global FIC Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global FIC Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global FIC Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global FIC Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global FIC Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global FIC Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global FIC Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global FIC Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America FIC Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe FIC Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific FIC Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America FIC Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa FIC Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa FIC Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Agios Company Information Table 72. Agios Business Overview Table 73. Agios FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Agios FIC Drugs Product Portfolio Table 75. Agios Recent Development Table 76. BMS Company Information Table 77. BMS Business Overview Table 78. BMS FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BMS FIC Drugs Product Portfolio Table 80. BMS Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim FIC Drugs Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Dermavant Sciences Company Information Table 87. Dermavant Sciences Business Overview Table 88. Dermavant Sciences FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dermavant Sciences FIC Drugs Product Portfolio Table 90. Dermavant Sciences Recent Development Table 91. Genentech Company Information Table 92. Genentech Business Overview Table 93. Genentech FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Genentech FIC Drugs Product Portfolio Table 95. Genentech Recent Development Table 96. Gilead Company Information Table 97. Gilead Business Overview Table 98. Gilead FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Gilead FIC Drugs Product Portfolio Table 100. Gilead Recent Development Table 101. Immunocore Company Information Table 102. Immunocore Business Overview Table 103. Immunocore FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Immunocore FIC Drugs Product Portfolio Table 105. Immunocore Recent Development Table 106. ImmunoGen Company Information Table 107. ImmunoGen Business Overview Table 108. ImmunoGen FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. ImmunoGen FIC Drugs Product Portfolio Table 110. ImmunoGen Recent Development Table 111. Mallinckrodt Company Information Table 112. Mallinckrodt Business Overview Table 113. Mallinckrodt FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mallinckrodt FIC Drugs Product Portfolio Table 115. Mallinckrodt Recent Development Table 116. Marinus Company Information Table 117. Marinus Business Overview Table 118. Marinus FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Marinus FIC Drugs Product Portfolio Table 120. Marinus Recent Development Table 121. Phathom Company Information Table 122. Phathom Business Overview Table 123. Phathom FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Phathom FIC Drugs Product Portfolio Table 125. Phathom Recent Development Table 126. Polarean lmaging Company Information Table 127. Polarean lmaging Business Overview Table 128. Polarean lmaging FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Polarean lmaging FIC Drugs Product Portfolio Table 130. Polarean lmaging Recent Development Table 131. Pfizer Company Information Table 132. Pfizer Business Overview Table 133. Pfizer FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Pfizer FIC Drugs Product Portfolio Table 135. Pfizer Recent Development Table 136. Eli Lilly Company Information Table 137. Eli Lilly Business Overview Table 138. Eli Lilly FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Eli Lilly FIC Drugs Product Portfolio Table 140. Eli Lilly Recent Development Table 141. Roche Company Information Table 142. Roche Business Overview Table 143. Roche FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Roche FIC Drugs Product Portfolio Table 145. Roche Recent Development Table 146. Merck Company Information Table 147. Merck Business Overview Table 148. Merck FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Merck FIC Drugs Product Portfolio Table 150. Merck Recent Development Table 151. Novartis Company Information Table 152. Novartis Business Overview Table 153. Novartis FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Novartis FIC Drugs Product Portfolio Table 155. Novartis Recent Development Table 156. Johnson & Johnson Company Information Table 157. Johnson & Johnson Business Overview Table 158. Johnson & Johnson FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Johnson & Johnson FIC Drugs Product Portfolio Table 160. Johnson & Johnson Recent Development Table 161. Sanofi Company Information Table 162. Sanofi Business Overview Table 163. Sanofi FIC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Sanofi FIC Drugs Product Portfolio Table 165. Sanofi Recent Development Table 166. North America FIC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America FIC Drugs Sales by Country (2021-2026) & (K Units) Table 168. North America FIC Drugs Sales Market Share by Country (2021-2026) Table 169. North America FIC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America FIC Drugs Sales Market Share Forecast by Country (2027-2032) Table 171. North America FIC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America FIC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 173. North America FIC Drugs Market Share by Country (2021-2026) Table 174. North America FIC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America FIC Drugs Market Share Forecast by Country (2027-2032) Table 176. Europe FIC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe FIC Drugs Sales by Country (2021-2026) & (K Units) Table 178. Europe FIC Drugs Sales Market Share by Country (2021-2026) Table 179. Europe FIC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe FIC Drugs Sales Market Share Forecast by Country (2027-2032) Table 181. Europe FIC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe FIC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe FIC Drugs Market Share by Country (2021-2026) Table 184. Europe FIC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe FIC Drugs Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific FIC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific FIC Drugs Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific FIC Drugs Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific FIC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific FIC Drugs Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific FIC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific FIC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific FIC Drugs Market Share by Country (2021-2026) Table 194. Asia-Pacific FIC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific FIC Drugs Market Share Forecast by Country (2027-2032) Table 196. Latin America FIC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America FIC Drugs Sales by Country (2021-2026) & (K Units) Table 198. Latin America FIC Drugs Sales Market Share by Country (2021-2026) Table 199. Latin America FIC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America FIC Drugs Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America FIC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America FIC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America FIC Drugs Market Share by Country (2021-2026) Table 204. Latin America FIC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America FIC Drugs Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa FIC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa FIC Drugs Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa FIC Drugs Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa FIC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa FIC Drugs Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa FIC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa FIC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa FIC Drugs Market Share by Country (2021-2026) Table 214. Middle East and Africa FIC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa FIC Drugs Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. FIC Drugs Distributors List Table 219. FIC Drugs Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. FIC Drugs Image Figure 2. Global FIC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FIC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global FIC Drugs Sales (2021-2032) & (K Units) Figure 5. FIC Single-target Drugs Image Figure 6. Global FIC Single-target Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. FIC Dual-target Drugs Image Figure 8. Global FIC Dual-target Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global FIC Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global FIC Drugs Market Share by Type 2025 VS 2032 Figure 11. North America FIC Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America FIC Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe FIC Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe FIC Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific FIC Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific FIC Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America FIC Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America FIC Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa FIC Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa FIC Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 FIC Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global FIC Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global FIC Drugs Market Share by Application 2025 VS 2032 Figure 31. North America FIC Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America FIC Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe FIC Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe FIC Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific FIC Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific FIC Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America FIC Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America FIC Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa FIC Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa FIC Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America FIC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America FIC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America FIC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America FIC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe FIC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe FIC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe FIC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe FIC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific FIC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific FIC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific FIC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific FIC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America FIC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America FIC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America FIC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America FIC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa FIC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa FIC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa FIC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa FIC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. FIC Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. FIC Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • FIC Single-target Drugs
  • FIC Dual-target Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Agios
  • BMS
  • Boehringer Ingelheim
  • Dermavant Sciences
  • Genentech
  • Gilead
  • Immunocore
  • ImmunoGen
  • Mallinckrodt
  • Marinus
  • Phathom
  • Polarean lmaging
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck
  • Novartis
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global FIC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global FIC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 FIC Drugs Market by Type
  6. 1.3.1 FIC Single-target Drugs
  7. 1.3.2 FIC Dual-target Drugs
  8. 1.4 Global FIC Drugs Market Size by Type
  9. 1.4.1 Global FIC Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global FIC Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global FIC Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America FIC Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe FIC Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific FIC Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America FIC Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa FIC Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 FIC Drugs Industry Trends
  2. 2.2 FIC Drugs Industry Drivers
  3. 2.3 FIC Drugs Industry Opportunities and Challenges
  4. 2.4 FIC Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by FIC Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by FIC Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by FIC Drugs Price (2021-2026)
  4. 3.4 Global FIC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FIC Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global FIC Drugs Company, Product Type & Application
  7. 3.7 Global FIC Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FIC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FIC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FIC Drugs Tier 1, Tier 2, and Tier 3
4 FIC Drugs Regional Status and Outlook
  1. 4.1 Global FIC Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global FIC Drugs Historic Market Size by Region
  3. 4.2.1 Global FIC Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global FIC Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global FIC Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global FIC Drugs Forecasted Market Size by Region
  7. 4.3.1 Global FIC Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global FIC Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global FIC Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 FIC Drugs by Application
  1. 5.1 FIC Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global FIC Drugs Market Size by Application
  6. 5.2.1 Global FIC Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global FIC Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global FIC Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America FIC Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe FIC Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific FIC Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America FIC Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa FIC Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Agios
  2. 6.1.1 Agios Company Information
  3. 6.1.2 Agios Business Overview
  4. 6.1.3 Agios FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Agios FIC Drugs Product Portfolio
  6. 6.1.5 Agios Recent Developments
  7. 6.2 BMS
  8. 6.2.1 BMS Company Information
  9. 6.2.2 BMS Business Overview
  10. 6.2.3 BMS FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BMS FIC Drugs Product Portfolio
  12. 6.2.5 BMS Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim FIC Drugs Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Dermavant Sciences
  20. 6.4.1 Dermavant Sciences Company Information
  21. 6.4.2 Dermavant Sciences Business Overview
  22. 6.4.3 Dermavant Sciences FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dermavant Sciences FIC Drugs Product Portfolio
  24. 6.4.5 Dermavant Sciences Recent Developments
  25. 6.5 Genentech
  26. 6.5.1 Genentech Company Information
  27. 6.5.2 Genentech Business Overview
  28. 6.5.3 Genentech FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Genentech FIC Drugs Product Portfolio
  30. 6.5.5 Genentech Recent Developments
  31. 6.6 Gilead
  32. 6.6.1 Gilead Company Information
  33. 6.6.2 Gilead Business Overview
  34. 6.6.3 Gilead FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gilead FIC Drugs Product Portfolio
  36. 6.6.5 Gilead Recent Developments
  37. 6.7 Immunocore
  38. 6.7.1 Immunocore Company Information
  39. 6.7.2 Immunocore Business Overview
  40. 6.7.3 Immunocore FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Immunocore FIC Drugs Product Portfolio
  42. 6.7.5 Immunocore Recent Developments
  43. 6.8 ImmunoGen
  44. 6.8.1 ImmunoGen Company Information
  45. 6.8.2 ImmunoGen Business Overview
  46. 6.8.3 ImmunoGen FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ImmunoGen FIC Drugs Product Portfolio
  48. 6.8.5 ImmunoGen Recent Developments
  49. 6.9 Mallinckrodt
  50. 6.9.1 Mallinckrodt Company Information
  51. 6.9.2 Mallinckrodt Business Overview
  52. 6.9.3 Mallinckrodt FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mallinckrodt FIC Drugs Product Portfolio
  54. 6.9.5 Mallinckrodt Recent Developments
  55. 6.10 Marinus
  56. 6.10.1 Marinus Company Information
  57. 6.10.2 Marinus Business Overview
  58. 6.10.3 Marinus FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Marinus FIC Drugs Product Portfolio
  60. 6.10.5 Marinus Recent Developments
  61. 6.11 Phathom
  62. 6.11.1 Phathom Company Information
  63. 6.11.2 Phathom Business Overview
  64. 6.11.3 Phathom FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Phathom FIC Drugs Product Portfolio
  66. 6.11.5 Phathom Recent Developments
  67. 6.12 Polarean lmaging
  68. 6.12.1 Polarean lmaging Company Information
  69. 6.12.2 Polarean lmaging Business Overview
  70. 6.12.3 Polarean lmaging FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Polarean lmaging FIC Drugs Product Portfolio
  72. 6.12.5 Polarean lmaging Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer FIC Drugs Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Eli Lilly
  80. 6.14.1 Eli Lilly Company Information
  81. 6.14.2 Eli Lilly Business Overview
  82. 6.14.3 Eli Lilly FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eli Lilly FIC Drugs Product Portfolio
  84. 6.14.5 Eli Lilly Recent Developments
  85. 6.15 Roche
  86. 6.15.1 Roche Company Information
  87. 6.15.2 Roche Business Overview
  88. 6.15.3 Roche FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Roche FIC Drugs Product Portfolio
  90. 6.15.5 Roche Recent Developments
  91. 6.16 Merck
  92. 6.16.1 Merck Company Information
  93. 6.16.2 Merck Business Overview
  94. 6.16.3 Merck FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Merck FIC Drugs Product Portfolio
  96. 6.16.5 Merck Recent Developments
  97. 6.17 Novartis
  98. 6.17.1 Novartis Company Information
  99. 6.17.2 Novartis Business Overview
  100. 6.17.3 Novartis FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Novartis FIC Drugs Product Portfolio
  102. 6.17.5 Novartis Recent Developments
  103. 6.18 Johnson & Johnson
  104. 6.18.1 Johnson & Johnson Company Information
  105. 6.18.2 Johnson & Johnson Business Overview
  106. 6.18.3 Johnson & Johnson FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Johnson & Johnson FIC Drugs Product Portfolio
  108. 6.18.5 Johnson & Johnson Recent Developments
  109. 6.19 Sanofi
  110. 6.19.1 Sanofi Company Information
  111. 6.19.2 Sanofi Business Overview
  112. 6.19.3 Sanofi FIC Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Sanofi FIC Drugs Product Portfolio
  114. 6.19.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America FIC Drugs Sales by Country
  2. 7.1.1 North America FIC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America FIC Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America FIC Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America FIC Drugs Market Size by Country
  6. 7.2.1 North America FIC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America FIC Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America FIC Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe FIC Drugs Sales by Country
  2. 8.1.1 Europe FIC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe FIC Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe FIC Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe FIC Drugs Market Size by Country
  6. 8.2.1 Europe FIC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe FIC Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe FIC Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific FIC Drugs Sales by Country
  2. 9.1.1 Asia-Pacific FIC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific FIC Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific FIC Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific FIC Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific FIC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific FIC Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific FIC Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America FIC Drugs Sales by Country
  2. 10.1.1 South America FIC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America FIC Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America FIC Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America FIC Drugs Market Size by Country
  6. 10.2.1 South America FIC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America FIC Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America FIC Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa FIC Drugs Sales by Country
  2. 11.1.1 Middle East and Africa FIC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa FIC Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa FIC Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa FIC Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa FIC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa FIC Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa FIC Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 FIC Drugs Value Chain Analysis
  2. 12.1.1 FIC Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 FIC Drugs Production Mode & Process
  7. 12.2 FIC Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 FIC Drugs Distributors
  10. 12.2.3 FIC Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst